ES2103257T3 - Antibiotico 9-r-azaciclo eritromicina. - Google Patents

Antibiotico 9-r-azaciclo eritromicina.

Info

Publication number
ES2103257T3
ES2103257T3 ES89109890T ES89109890T ES2103257T3 ES 2103257 T3 ES2103257 T3 ES 2103257T3 ES 89109890 T ES89109890 T ES 89109890T ES 89109890 T ES89109890 T ES 89109890T ES 2103257 T3 ES2103257 T3 ES 2103257T3
Authority
ES
Spain
Prior art keywords
eritromicina
azaciclo
antibiotic
derivatives
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89109890T
Other languages
English (en)
Inventor
Richard J Pariza
Clarence J Maring
Paul A Lartey
Larry L Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2103257T3 publication Critical patent/ES2103257T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

SE PRESENTAN ANTIBIOTICOS SEMISINTETICOS CON PROPIEDADES TERAPEUTICAS MEJORADAS. EN PARTICULAR DERIVADOS 9 - R - AZACICLICOS DE LA ERICTROMICINA, SUS DERIVADOS Y SUS SALES Y ESTERES PRESENTAN UNA ACTIVIDAD ANTIMICROBIANA SUPERIOR COMPARADA CON OTROS COMPUESTOS MACROLIDOS.
ES89109890T 1988-06-07 1989-06-01 Antibiotico 9-r-azaciclo eritromicina. Expired - Lifetime ES2103257T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/203,400 US5075289A (en) 1988-06-07 1988-06-07 9-r-azacyclic erythromycin antibiotics

Publications (1)

Publication Number Publication Date
ES2103257T3 true ES2103257T3 (es) 1997-09-16

Family

ID=22753840

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89109890T Expired - Lifetime ES2103257T3 (es) 1988-06-07 1989-06-01 Antibiotico 9-r-azaciclo eritromicina.

Country Status (13)

Country Link
US (1) US5075289A (es)
EP (1) EP0345627B1 (es)
JP (1) JP2922922B2 (es)
KR (1) KR0132671B1 (es)
AT (1) ATE151772T1 (es)
AU (1) AU609307B2 (es)
CA (1) CA1328258C (es)
DE (1) DE68927967T2 (es)
DK (1) DK172754B1 (es)
ES (1) ES2103257T3 (es)
GR (1) GR3023617T3 (es)
IL (1) IL90434A0 (es)
NZ (1) NZ229328A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217960A (en) * 1991-05-03 1993-06-08 Abbott Laboratories Erythromycin derivatives
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US6436906B1 (en) * 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
AP2007004026A0 (en) * 2004-12-21 2007-06-30 Pfizer Prod Inc Macrolides

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3652537A (en) * 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
GB1341022A (en) * 1970-04-13 1973-12-19 Lilly Industries Ltd Erythromycylamine compounds
US3681322A (en) * 1970-04-13 1972-08-01 Lilly Co Eli Adducts of aliphatic and araliphatic aldehydes and erythromycylamine or erythromycyl b amine
ZA71763B (en) * 1970-04-13 1972-03-29 Lilly Industries Ltd Erythromycylamines via hydrazones
GB1345524A (en) * 1970-09-30 1974-01-30 Lilly Industries Ltd N-heteroarylidene erythomycylamines
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines
GB1344629A (en) * 1970-09-30 1974-01-23 Lilly Industries Ltd Erythromycin azine derivatives
US3983103A (en) * 1973-01-19 1976-09-28 Pliva Pharmaceutical And Chemical Works N-(Benzenesulfonyl)-erythromycylamine derivatives
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU35363B (en) * 1974-01-14 1980-12-31 Pliva Zagreb Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
US3992264A (en) * 1974-02-04 1976-11-16 Hoffmann-La Roche Inc. Antibiotic 1745A/X and methods for the production thereof
US4070376A (en) * 1974-02-04 1978-01-24 Hoffmann-La Roche, Inc. Antibiotic 1745A/X and methods for the production thereof
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4283527A (en) * 1980-04-01 1981-08-11 Pfizer Inc. Erythromycylamine 11,12-carbonate and derivatives thereof
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4492688A (en) * 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
GR80277B (en) * 1983-09-06 1985-01-04 Pfizer Azahomoerythromycin b derivatives and intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
GB8421429D0 (en) * 1984-08-23 1984-09-26 Beecham Group Plc Chemical compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
ES552858A1 (es) * 1985-03-12 1987-11-01 Beecham Group Plc Un procedimiento para la preparacion de derivados de eritromicina.
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−n−メチルエリスロマイシン誘導体
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
ZA87591B (en) * 1986-02-03 1988-09-28 Lilly Co Eli Novel derivatives of eryhromycylamine
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
DK172754B1 (da) 1999-06-28
AU3610289A (en) 1989-12-14
ATE151772T1 (de) 1997-05-15
EP0345627A3 (en) 1991-09-11
DE68927967T2 (de) 1997-10-02
DK276289D0 (da) 1989-06-06
DK276289A (da) 1989-12-08
JP2922922B2 (ja) 1999-07-26
EP0345627A2 (en) 1989-12-13
IL90434A0 (en) 1990-01-18
US5075289A (en) 1991-12-24
AU609307B2 (en) 1991-04-26
CA1328258C (en) 1994-04-05
GR3023617T3 (en) 1997-08-29
KR910000785A (ko) 1991-01-29
DE68927967D1 (de) 1997-05-22
JPH0267294A (ja) 1990-03-07
KR0132671B1 (ko) 1998-04-14
NZ229328A (en) 1991-04-26
EP0345627B1 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
RU93050124A (ru) Новые производные эритромицина, метод их получения и фармацевтическая композиция на их основе
FR2587344B1 (fr) Antibiotiques du type des macrolides et leur preparation
ES8607335A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
PT876388E (pt) Derivados de eritromicina triciclica
ATE66001T1 (de) Makrolid-antibiotikaderivate.
ES2111616T3 (es) Compuestos de ciclohexapeptidil bisamina.
ES2103257T3 (es) Antibiotico 9-r-azaciclo eritromicina.
DK254588D0 (da) Antibiotika
ES2098455T3 (es) Compuestos de ciclohexapeptidil propanolamina.
DK0797579T3 (da) Erythromycin A-9-O-oxim-derivater udstyret med antibiotisk aktivitet
DE68920898D1 (de) Aglykone von A/16686-Antibiotika.
MY104067A (en) Epipodophyllotoxin glucoside 4''-acyl derivatives
GR3004655T3 (es)
DK107189D0 (da) Antitumor aktive forbindelser
MA Comparative efficacies of macrolide antibiotics [erythromycin and roxithromycin] and cefadroxil in management of skin infections caused by staphylococcus aureus
PL292767A1 (en) Method of obtaining novel derivatives of 10,11,12,13--tetrahydrodemycosine
RU96124168A (ru) Способ лечения больных инфекционным эндокардитом в раннем послеоперационном периоде
IT8722156A0 (it) Derivati pirido benzoiazinici dotati di elevata attivita'antibatterica e di elevata biodisponibilita' tissutale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345627

Country of ref document: ES